Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Ovarian Neoplasms D010051 10 associated lipids
Pain D010146 64 associated lipids
Contusions D003288 3 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Cattle Diseases D002418 24 associated lipids
Fatty Liver D005234 48 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Embolism D011655 5 associated lipids
Coronary Disease D003327 70 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypothyroidism D007037 32 associated lipids
Rhinitis D012220 10 associated lipids
Hypercapnia D006935 5 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Pain, Postoperative D010149 13 associated lipids
Asthma D001249 52 associated lipids
Kidney Diseases D007674 29 associated lipids
Femoral Fractures D005264 7 associated lipids
Weight Gain D015430 101 associated lipids
Hyperemia D006940 25 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Acidosis D000138 13 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Ulcer D014456 16 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Proteinuria D011507 30 associated lipids
Arteriosclerosis D001161 86 associated lipids
Magnesium Deficiency D008275 9 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Fetal Diseases D005315 8 associated lipids
Glomerulonephritis D005921 35 associated lipids
Cerebral Hemorrhage D002543 13 associated lipids
Sepsis D018805 11 associated lipids
Leukopenia D007970 9 associated lipids
Respiratory Insufficiency D012131 10 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Nephrotic Syndrome D009404 11 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Seizures D012640 87 associated lipids
Peptic Ulcer D010437 19 associated lipids
Birth Weight D001724 23 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Thromboembolism D013923 6 associated lipids
Nasal Polyps D009298 26 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Cuiper LL et al. Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2. 1996 J. Appl. Physiol. pmid:8847301
Nowak J et al. Thromboxane metabolite excretion in patients with hand-arm vibration syndrome. 1996 Clin Physiol pmid:8842572
Stichtenoth DO et al. Increased total body synthesis of prostacyclin in rats with adjuvant arthritis. 1995 Nov-Dec Prostaglandins pmid:8838242
Muller M and Sorrell TC Inhibition of the human platelet cyclooxygenase response by the naturally occurring phenazine derivative, 1-hydroxyphenazine. 1995 Nov-Dec Prostaglandins pmid:8838240
Fylling AC et al. Kinetic and structural evidence for the identification of 11-hydroxythromboxane B2 dehydrogenase as cytosolic aldehyde dehydrogenase. 1995 Nov-Dec Prostaglandins pmid:8838239
Meade CJ et al. Pulmonary pharmacology of DT-TX 30 SE, a potent selective combined thromboxane synthetase inhibitor and receptor antagonist, in guinea pigs. 1996 Jpn. J. Pharmacol. pmid:8835638
Osiovich H et al. Cardiopulmonary effects of tumor necrosis factor-alpha in the piglet: influence of cyclooxygenase inhibition. 1995 Biol. Neonate pmid:8835089
Myers SI et al. Long-term resuscitation of hemorrhage/reperfusion injury (H/R) stimulates renal PGE2 release. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8832762
Mizugaki M et al. Microdetermination of 11-dehydrothromboxane B3 in human urine by gas chromatography--selected-ion monitoring using (18O2) analogue as an internal standard. 1995 Rapid Commun. Mass Spectrom. pmid:8829485
Ishibashi M et al. Identification of 11-dehydro-2,3-dinorthromboxane B3 in human urine based on the mass spectral properties of 11-dehydrothromboxane B3 and related compounds. 1995 Rapid Commun. Mass Spectrom. pmid:8829476
Mitten LA et al. Phenylbutazone increases right atrial pressure and heart rate of running horses. 1996 J. Appl. Physiol. pmid:8828679
Watanabe M et al. [Changes in platelet sensitivity to thromboxane A2 in pediatric patients with nephrotic syndrome]. 1996 Nihon Jinzo Gakkai Shi pmid:8828355
Meenan J et al. Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. 1996 Eur J Gastroenterol Hepatol pmid:8823572
Wagner RS et al. Activation of thromboxane A2 receptors alters lipopolysaccharide-induced adherence of THP-1 cells. 1996 Shock pmid:8821102
Davì G et al. Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus. 1996 Thromb. Haemost. pmid:8819248
Galbraith EA and McKellar QA Protein binding and in vitro serum thromboxane B2 inhibition by flunixin meglumine and meclofenamic acid in dog, goat and horse blood. 1996 Res. Vet. Sci. pmid:8819199
Landoni MF et al. Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. 1996 Res. Vet. Sci. pmid:8819190
Yoshida SH et al. Dietary Juniperis virginiensis seed oil decreased pentobarbital-associated mortalities among DBA/1 mice treated with collagen-adjuvant emulsions. 1996 J Lipid Mediat Cell Signal pmid:8816989
Pace-Asciak CR et al. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. 1996 Clin. Chim. Acta pmid:8814965
Zhen ZY et al. Experimental study on microthrombi and myocardial injuries. 1996 Microvasc. Res. pmid:8812763
Giulian D et al. Activated microglia are the principal glial source of thromboxane in the central nervous system. 1996 Neurochem. Int. pmid:8808790
González ET et al. Prostanoid modulation of glucose transport in isolated diabetic rat uterus. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8804128
Feng J et al. Beneficial effects of iloprost cardioplegia in ischemic arrest in isolated working rat heart. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8804125
Fekkes D et al. Eicosanoid and amino acid metabolism in transient acute psychoses with psychedelic symptoms. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8804122
Lewy RI et al. Intravenous heparin initiates in-vivo synthesis and release of thromboxane in angina pectoris. 1979 Lancet pmid:87990
Morrow JD et al. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo. 1996 J. Biol. Chem. pmid:8798513
Fox GA et al. Cyclooxygenase inhibition and vascular reactivity in a rat model of hyperdynamic sepsis. 1996 J. Cardiovasc. Pharmacol. pmid:8797133
Sakurai S et al. Synthesis of [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives containing pyridyl or imidazolyl groups and their thromboxane A2 receptor antagonistic and thromboxane A2 synthase inhibitory activities. 1996 Chem. Pharm. Bull. pmid:8795270
Ko FN et al. Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation. 1996 J. Pharm. Pharmacol. pmid:8794990
Uematsu T et al. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers. 1996 J. Pharm. Pharmacol. pmid:8794987
Eriksson M et al. Beneficial effects of pre-treatment with vitamin A on cardiac and pulmonary functions in endotoxaemic pigs. 1996 Acta Anaesthesiol Scand pmid:8792882
Collins CE et al. Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. 1996 Aliment. Pharmacol. Ther. pmid:8791957
Aïssa J et al. Biochemical and cellular effects of heparin-protamine injection in rabbits are partially inhibited by a PAF-acether receptor antagonist. 1996 Eur. J. Pharmacol. pmid:8791000
Vaskonen T et al. Interrelationships between salt and fish oil in stroke-prone spontaneously hypertensive rat. 1996 Blood Press. pmid:8790929
Raptopoulos D et al. The effect of xylazine on plasma thromboxane B2 concentration in sheep. 1995 J. Vet. Pharmacol. Ther. pmid:8789696
Bell SJ et al. Dietary fish oil and cytokine and eicosanoid production during human immunodeficiency virus infection. 1996 Jan-Feb JPEN J Parenter Enteral Nutr pmid:8788262
Zheng NX et al. Pharmacokinetic and pharmacodynamic studies of a thromboxane synthetase inhibitor, ozagrel, in rabbits. 1995 Biol. Pharm. Bull. pmid:8787798
Cuzzolin L et al. Effect of single and repeated doses of a new nitroderivative of acetylsalicylic acid on platelet TXA2 production in rats. 1996 Life Sci. pmid:8786689
Uhlig S et al. Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. 1996 Mol. Med. pmid:8784790
Gennaro M et al. Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion. 1996 Cardiovasc Surg pmid:8782946
Nabe T et al. Sephadex G-200-induced eosinophil infiltration into airways in non-sensitized and sensitized guinea pigs, and responsiveness of the cells to stimuli in vitro. 1996 Jpn. J. Pharmacol. pmid:8774762
Quoc KP and Pascaud M Effects of dietary gamma-linolenic acid on the tissue phospholipid fatty acid composition and the synthesis of eicosanoids in rats. 1996 Ann. Nutr. Metab. pmid:8773734
Madan ZM and Sainani GS Effect of aspirin treatment on plasma levels of keto PGF 1 alpha and thromboxane B2. 1995 J Assoc Physicians India pmid:8773058
Mehta PJ et al. More uses of known drugs. 1995 J Assoc Physicians India pmid:8773057
Closa D et al. Hepatic involvement in pancreatitis-induced lung damage. 1996 Am. J. Physiol. pmid:8772495
Abernathy VJ et al. C-reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs. 1996 Am. J. Physiol. pmid:8770090
Shirabe K et al. Inhibition of thromboxane A2 activity during warm ischemia of the liver. 1996 J. Surg. Res. pmid:8769950
Qiu BS et al. Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. 1996 Dig. Dis. Sci. pmid:8769290
Hrboticky N et al. Linoleic acid esterified in low density lipoprotein serves as substrate for increased arachidonic acid synthesis in differentiating monocytic cells. 1996 Biochim. Biophys. Acta pmid:8765140
Fleisch JH et al. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor. 1996 J. Pharmacol. Exp. Ther. pmid:8764358